JENNIFER SHERMAN: Open Payments
NPI 1366076424 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 56 payments from 13 companies in 2025. Trend: 2023 $705 · 2024 $1,364 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $359 |
| Organon LLC | 5 | $115 |
| Incyte Corporation | 5 | $111 |
| Novartis Pharmaceuticals Corporation | 3 | $88 |
| ABBVIE INC. | 4 | $76 |
| Amgen Inc. | 3 | $75 |
| UCB, Inc. | 3 | $59 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $56 |
| PFIZER INC. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
Products named: ILUMYA, Winlevi, OPZELURA, COSENTYX, SKYRIZI, Otezla, VTAMA, Bimzelx.
Industry payments across NY — which companies pay providers there.
